NCT03426462

Brief Summary

In order to determine the speed of onset of the anaesthetic propofol in children, investigators will compare the two age groups 1-6 years vs 8-13 years. The primary outcome measure is the time to peak effect of a bolus of proposal, which is measured by analysing the electroencephalogram by using the permutation entropy. Further pharmacodynamic modelling will enable investigators to quantify the difference with age in the hypnotic effect of propofol.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Apr 2018

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 25, 2018

Completed
14 days until next milestone

First Posted

Study publicly available on registry

February 8, 2018

Completed
2 months until next milestone

Study Start

First participant enrolled

April 23, 2018

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 4, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 4, 2018

Completed
Last Updated

January 30, 2019

Status Verified

January 1, 2019

Enrollment Period

8 months

First QC Date

January 25, 2018

Last Update Submit

January 29, 2019

Conditions

Keywords

PharmacodynamicPermutation EntropyEEG

Outcome Measures

Primary Outcomes (1)

  • Time to peak effect of a propofol bolus

    This is the time from the start of the propofol bolus administration to the maximal suppression of the electroencephalogram; per subject two boli will be administered

    up to 20 minutes from baseline until peak effect following second bolus administration

Study Arms (2)

Age 1-6 years

EXPERIMENTAL

Induction of anesthesia with propofol using infusion pumps that are programmed with a pharmacokinetic model to achieve a calculated plasma concentration of the drug; this is followed by two anesthetic deepening episodes. The target plasma concentrations achieved, as calculated by the programmed pump, is exactly the same in both age groups.

Drug: Propofol

Age 8-13 years

EXPERIMENTAL

Induction of anesthesia with propofol using infusion pumps that are programmed with a pharmacokinetic model to achieve a calculated plasma concentration of the drug; this is followed by two anesthetic deepening episodes. The target plasma concentrations achieved, as calculated by the programmed pump, is exactly the same in both age groups.

Drug: Propofol

Interventions

Induction of anesthesia and two further deepening episodes will be performed whilst recording the electroencephalogram.

Age 1-6 yearsAge 8-13 years

Eligibility Criteria

Age1 Year - 13 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • The study population will be healthy children in the ranges of 1-6 and 8-13 years of age having surgery with American Society of Anaesthesia (ASA) grades I-II (ie. no prior functional limitation due to comorbidities) that fulfil the following points:
  • parental written consent obtained at least a day prior to begin of the subject's study episode; and
  • the child is appropriate for induction and maintenance of anaesthesia with propofol.

You may not qualify if:

  • Any significant subject co-morbidity (ASA III or IV);
  • Withdrawal of consent/assent at any point in the study;
  • Failure to cannulate a peripheral vein prior to induction after two attempts;
  • Any other reason making IV induction with propofol impossible;
  • Allergy to propofol (or its emulsion carrier), Eutectic Mixture of Local Anesthetics (EMLA) cream or Nitrous Oxide (N2O);
  • previous enrolment in the study;
  • Any anaesthetic problem that would take precedence over completion of the study protocol.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universitäts Kinderspital beider Basel

Basel, 4051, Switzerland

Location

MeSH Terms

Interventions

Propofol

Intervention Hierarchy (Ancestors)

PhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic Chemicals

Study Officials

  • Gil Gavel

    Universitäts Kinderspital beider Basel (UKBB)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The analysis of the electroencephalogram will be blinded to the age of the participant.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Age groups 1-6 years will be compared with 8-13 years whilst undergoing propofol anesthesia to detect whether there is indeed a difference in the speed of onset of the hypnotic effect of the drug.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 25, 2018

First Posted

February 8, 2018

Study Start

April 23, 2018

Primary Completion

December 4, 2018

Study Completion

December 4, 2018

Last Updated

January 30, 2019

Record last verified: 2019-01

Data Sharing

IPD Sharing
Will not share

Locations